Please complete at least one question.
Dr James Larkin - The Royal Marsden, London, UK
Dr Larkin presents results from Checkpoint 067, a trail of combined nivolumab and ipilimumab for advanced melanoma, at AACR 2017.
Slides from this presentation are available here, and you can read more about the results here.
Dr Suzanne Topalian spoke with ecancer about these results here.